SINGAPORE and PHILADELPHIA, Jan. 24, 2025 /PRNewswire/ — Nuevocor, an IND-stage biotechnology company dedicated to developing functional cures to treat cardiomyopathies with aberrant mechanobiology, today announces the appointment of Dr. Andreas Wallnöfer as Chairman of Nuevocor’s Board…
